Pancreatic Neuroendocrine Tumors in Men1

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-04-08
Clinical Trial Update: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment [Phase 3]
Phase 3 trial evaluating somatostatin analogs versus no treatment for non-functioning pancreatic neuroendocrine tumors in MEN1.